PI-LAB-2026-069

Retatrutide, Independent Lab Report

Retatrutide 5mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 99.7% met the stated ≥99% claim. Content measured 100.2% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
99.7%

Label claimed ≥99%

Content accuracy
100.2%

5.01mg measured against 5mg claimed

Test recency
Current cycle

Published 3 months ago

Specimen PI-LAB-2026-069 Tested by Vantage Analytical Labs 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 99% 99.7% Meets claim
Identity (MS) Retatrutide Confirmed Matches label
Content 5 mg 5.01 mg Within 5% of label

Methodology & chain of custody

Reversed-phase HPLC purity analysis with UV detection at 214nm.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
R1197-26
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Content verification

Original laboratory report: PI-LAB-2026-069-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified
Tirzepatide
Purity 98.2% Discrepancy

More Tests, Retatrutide

Retatrutide Vector Peptide Supply
Purity 97.6% Verified
Retatrutide Cardinal Metabolic Clinic
Purity 93.7% Verified
Retatrutide Research Peptides Co.
Purity 98.4% Verified